Gadolinium Lawsuit Optimark Gadolinium MRI Contrasting Agent
 
Gadolinium based MRI contrasting agents have been known to cause serious or even fatal side effects such as Nephrogenic Systemic Fibrosis, aka. NSF. If you or a loved one have been injured by Gadolinium side effects you may be entitled to compensation. Contact the lawyers of Ennis & Ennis, P.A. today about a Gadolinium drug lawsuit.
Gadolinium Side Effects - Gadolinium Lawyer - Gadolinium Drug Lawsuits - Gadolinium NSF - Nefrogenic Systemic Fibrosis -Gadolinium Attorney
Free Case Evaluation

Gadolinium Side Effects Lawsuit News:

Adverse Reactions from Gadolinium-Based Contrast Agents Used During MRI Rarely Occur, Study Suggests

Bookmark and Share 

- Health Canal

01/20/2010 - Acute adverse reactions from gadolinium-based contrast agents used during magnetic resonance imaging (MRI) to help improve the information seen on the images rarely occur, according to a study published in the February issue of the American Journal of Roentgenology.

Since approval of the first gadolinium-based contrast agent the use of contrast agents for MRI has been evolving. “These agents are useful in the diagnosis of several diseases and conditions and are considered generally safe in clinical practice,” said Hani H. Abujudeh, MD, lead author of the study. “However the association between the use of gadolinium-based agents and nephrogenic systemic fibrosis (NSF) has sparked controversy over the years,” said Abujudeh.

NSF is a potentially lethal systemic disease that has raised the concern over the use of gadolinium-based contrast agents for imaging of patients with underlying renal impairment. “When prescribing gadolinium-based contrast agents, radiologists need to consider not only the risk of NSF but also the risk of acute adverse reactions,” he said.

The study, performed at Massachusetts General Hospital and Harvard Medical School, included a total of 32,659 gadolinium-based contrast injections for MRI examinations. “A total of 51 acute adverse reactions occurred in 50 patients, accounting for 0.16 percent of all administrations,” said Abujudeh. The majority of the reactions that did occur were mild including nausea, vomiting, headache, and dizziness. However six moderate and two severe reactions did occur.

“In our study, acute adverse reactions were rare. However it is still important that radiologists and patients be aware of the risks associated with the use of gadolinium-based contrast agents, especially those associated with NSF,” said Abujudeh.

This study appears in the February issue of the American Journal of Roentgenology. For a copy of the full study or to request an interview with Dr. Abudujeh, please contact Heather Curry via email at hcurry@acr-arrs.org or at 703-390-9822.

If you or a loved one have experienced Gadolinium side effects you may be entitled to compensation. Contact the Gadolinium attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Gadolinium side effects, a possible Gadolinium lawsuit, or any other type of Gadolinium litigation.

 

 

Required fields in yellow
 
Name:
Email:
 
Telephone: (123-123-1234)
 
Mailing Address:
 
City:
 
State:
 
Zip Code:
Please List Defective Product You Are Inquiring About:
Please List Any Side Effects, Injuries, or Property Damage:
Additional Information:
 
 

 

 

Nationwide Free Case Evaluations: 1-800-856-6405